Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Is AstraZeneca PLC AZN Among the U.K. Dividend Champions for 2024?

January 01, 2025
The U.K. dividend landscape has always been attractive for investors, with a multitude of companies offering consistent returns. One company that investors have kept a keen eye on is AstraZeneca PLC (AZN).

AstraZeneca is a global biopharmaceutical company that focuses on innovative medicines and products improving patient outcomes. Over the years, the company has established itself as a leader in the pharmaceutical industry, contributing significantly to medical advancements.

Investors looking for reliable dividend-paying stocks may be interested to know if AstraZeneca is part of the U.K.'s dividend champions for 2024. The potential inclusion in this prestigious group can bring considerable attention and stability to the share price.

While we can't make any definitive claims about AstraZeneca's future dividends, the company's strong financial performance suggests it has the potential to be among the U.K. Dividend Champions for 2024. With a proven track record of delivering value to shareholders, AstraZeneca has consistently raised its dividends over the years.

However, it's important to note that investing in stocks carries risks, and past performance is not indicative of future results. It's recommended for investors to consult professionals who can provide a comprehensive analysis and prognosis of AstraZeneca's stock movement.

For those seeking expert advice, Stocks Prognosis offers professional insights and forecasts on various stocks, including AstraZeneca PLC. Their team of experts analyzes market trends, company fundamentals, and external factors to provide reliable predictions on stock performance.

Investors looking to make informed decisions can benefit from the expertise of Stocks Prognosis. Considering the potential inclusion of AstraZeneca in the U.K. dividend champions for 2024, seeking professional guidance can help navigate the uncertainties and make informed investment choices.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNSeptember 3, 2025ASTRAZENECA PLC Hits QuantWave Forecast, Generating 16.24% Profit  ~2 min.

ASTRAZENECA PLC has successfully reached the price target forecasted by QuantWave on July 11, 2025. The forecast indicated a long position with a price of 70.64 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Hits 11.81% Profit Target as Forecasted by QuantWave  ~1 min.

ASTRAZENECA PLC's stock has successfully reached the price target forecasted by QuantWave, resulting in a profit of 11.81%. The forecast signal was given on 2025-08-01 when the stock was trading at 73....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits QuantWave Price Target with Profit of 19.38%  ~1 min.

On July 17, 2025, QuantWave, the automated forecasting platform, issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.78 $....


AZNSeptember 3, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 17.98% Profit  ~1 min.

On July 16, 2025, QuantWave's automated forecasting platform issued a signal for ASTRAZENECA PLC, predicting a long position with the stock trading at $69.6....


AZNAugust 25, 2025AstraZeneca's Breakthrough Study on Advanced Biliary Tract Cancer  ~1 min.

AstraZeneca PLC has recently announced groundbreaking results from their new study on advanced biliary tract cancer, showing promising potential for a new treatment option in cancer care....


AZNAugust 22, 2025ASTRAZENECA PLC Hits Price Target Forecast with 20.55% Profit  ~1 min.

On January 23, 2025, QuantWave issued a long signal for ASTRAZENECA PLC with a price of 67.17 $. The forecast proved to be accurate as the stock reached the target price of 80....


AZNAugust 22, 2025ASTRAZENECA PLC Stock Hits QuantWave's Price Target Forecast with 14.63% Profit  ~1 min.

ASTRAZENECA PLC stock has successfully reached the price target forecast provided by QuantWave, resulting in a profitable outcome for investors....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Yielding 14.58% Profit - QuantWave Prediction Success  ~2 min.

On June 18, 2025, QuantWave issued a long forecast signal for ASTRAZENECA PLC when the stock was trading at $70.27....


AZNAugust 20, 2025ASTRAZENECA PLC Hits Price Target Forecast with 16.44% Profit: A Win for QuantWave  ~1 min.

ASTRAZENECA PLC, one of the leading pharmaceutical companies, has seen its stock price hit the forecasted target with a substantial 16....


AZNAugust 20, 2025ASTRAZENECA PLC Stock Hits Price Target, Generating 13.99% Profit for QuantWave Users  ~2 min.

On July 2, 2025, QuantWave, an automated forecasting platform, issued a price target forecast for ASTRAZENECA PLC with a long signal at a price of 70.64 $....


AZNJanuary 1, 2025Stocks Prognosis: Is AstraZeneca PLC AZN Set to Become a U.K. Dividend Champion by 2024?  ~2 min.

AstraZeneca PLC, a leading global pharmaceutical company, is garnering attention from investors as it seeks to establish itself as a U.K. Dividend Champion by 2024....


AZNDecember 26, 2024AstraZeneca Faces Investigation in China; Shares Plummet  ~2 min.

AstraZeneca PLC (AZN) shares dropped significantly today following reports of a probe by the People's Republic of China (PRC) into alleged fraud and corruption within the company....


AZNOctober 30, 2024Astrazeneca AZN Declines More Than Market: Some Information for Investors  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has experienced a decline in its stock value, performing worse than the overall market....


AZNJanuary 2, 2025AstraZeneca PLC AZN emerges as a frontrunner in developing innovative Covid-19 treatments  ~1 min.

AstraZeneca PLC, a renowned biopharmaceutical company, has proven its mettle in the race to develop effective Covid-19 treatments....


AZNDecember 28, 2024Why Is AstraZeneca PLC AZN Among the Best European Dividend Stocks To Buy Now  ~2 min.

AstraZeneca PLC (AZN) has emerged as one of the top European dividend stocks to consider investing in....